Epidermal growth factor receptor (EGFR), a tyrosine kinase receptor whose activation leads to receptor dimerization and tyrosine autophosphorylation, mediates tumor cell survival and proliferation in lung cancer, colorectal cancer (CRC) and breast cancer (1–4). Here, EGFR is linked to breast carcinoma.